comparemela.com

Latest Breaking News On - Alexion ultomiris - Page 1 : comparemela.com

Argenx s Vyvgart and Alexion s Ultomiris Go Toe-to-Toe in Generalized Myasthenia Gravis, According to Spherix Global Insights

/PRNewswire/ Competition in the generalized myasthenia gravis (gMG) market is heating up with the launches of argenx s Vyvgart and Alexion s Ultomiris.

Argenx s Vyvgart and Alexion s Ultomiris Go Toe-to-Toe in Generalized Myasthenia Gravis, According to Spherix Global Insights

/PRNewswire/ Competition in the generalized myasthenia gravis (gMG) market is heating up with the launches of argenx s Vyvgart and Alexion s Ultomiris.

Alexion children s book series aims to help parents talk to kids about life with a rare disease

Rachel Pegram, who has the rare disease generalized myasthenia gravis, wanted an easier way to explain her condition to her three-year-old daughter. So she worked with AstraZeneca's Alexion unit to create "Klara's Talent," the first in a children's book series to help families discuss rare diseases with their kids.

Alexion ALS drug s approval chances sink: regulatory roundup

Alexion ALS drug s approval chances sink: regulatory roundup
clinicaltrialsarena.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from clinicaltrialsarena.com Daily Mail and Mail on Sunday newspapers.

AstraZeneca s Alexion buy takes first hit as Ultomiris fails in rare neurodegenerative disease

Bad news has struck first for AstraZeneca’s newly acquired Alexion rare disease franchise. AstraZeneca has decided to cap a trial testing Ultomiris in the rare neurodegenerative disease amyotrophic lateral sclerosis, citing lack of efficacy.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.